NCT07701369Recruiting
Relevance of Artificial Intelligence-Assisted Echocardiography for Left Ventricular Ejection Fraction Assessment in Geriatric Patients
Source: ClinicalTrials.gov · Last updated 28 Jul 2026
Brief summary (registry, in English)
Heart failure (HF) is the leading cause of hospitalization among adults aged 80 years and older and represents a major diagnostic challenge in geriatric medicine due to frequently atypical clinical presentations and the presence of multiple comorbidities. Although transthoracic echocardiography (TTE) with measurement of left ventricular ejection fraction (LVEF) remains the gold standard for cardiac functional assessment, access to echocardiography is often limited in geriatric wards. Recent advances in artificial intelligence (AI) have enabled the development of portable ultrasound devices and automated image analysis software capable of providing reliable and reproducible LVEF measurements. AI-assisted automated LVEF assessment (AutoEF-AI) may therefore represent a valuable alternative to conventional echocardiography for the cardiac evaluation of older patients with heart failure.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- First submitted
- 1 Jul 2026
- Start date
- Jul 2026
- Primary completion date
- Jun 2028
- Lead sponsor
- Gérond'if
- Diseases
- Heart failure
- NCT number
- NCT07701369
What you commit to
- Study type: Interventional
- Planned participants: 130
- From Jul 2026 to the primary completion date, Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Hemodynamic instability preventing echocardiographic assessment.
- Contraindication to transthoracic echocardiography.
- Patients under legal protection (guardianship, curatorship, or judicial protection measures) or unable to provide informed consent.
- Refusal to participate in the study.
Who the study is looking for
- Age ≥75 years.
- Hospitalization in a geriatric unit for acute heart failure according to the 2021 ESC diagnostic criteria.
- Hemodynamic stability at the time of echocardiographic examination.
- Ability to understand study information, provide written informed consent, and willingness to participate.
- Affiliation with, or beneficiary of, a health insurance/social security scheme.
Age in the registry: 75 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Broca Hospital Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.